AIFarm, Ltd.
AIFM · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $56 | $219 | $76 | $135 |
| SG&A Expenses | $56 | $219 | $76 | $135 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $56 | $219 | $76 | $135 |
| Operating Income | -$56 | -$219 | -$76 | -$135 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$60 | $0 | $0 | $0 |
| Pre-Tax Income | -$116 | -$219 | -$76 | -$135 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | -$116 | -$219 | -$76 | -$135 |
| % Margin | – | – | – | – |
| EPS | -0.19 | -0.39 | -0.14 | -0.26 |
| % Growth | 51.3% | -178.6% | 46.2% | – |
| EPS Diluted | -0.19 | -0.39 | -0.14 | -0.26 |
| Weighted Avg Shares Out | 616 | 562 | 559 | 527 |
| Weighted Avg Shares Out Dil | 616 | 562 | 559 | 527 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $56 | $219 | $76 | $135 |
| EBITDA | -$60 | -$219 | -$76 | -$135 |
| % Margin | – | – | – | – |